2012 CMIO Compensation Survey: Those earning big bonuses, highest pay

Hodge Practice Podge - 70.95 Kb
Seventeen percent of this year’s CMIO Compensation Survey respondents earn a salary of $300,000 or more. Here is a closer look at said group.

This group is much more likely to work for a multi-hospital organization—70 percent compared with 44 percent overall. While the largest age category in the overall results is 41 to 45 years old, this group is more likely to be older: only 5 percent are 41 to 45, 30 percent are 46 to 50, 20 percent are 51 to 55, 25 percent are 56 to 60 and 15 percent are over 60.

More than half (53 percent) of this subgroup expect no change in the amount of time they spend on CMIO duties, compared with 68 percent overall. Thirty percent of this group expects no salary increase while 10 percent expect a raise of less than 2 percent, 45 percent expect 2-4 percent, 10 percent expect 4-6 percent and 5 percent expect 10-12 percent.

Forty percent of this group expects a bonus the same as last year, 30 percent expect more than last year, 5 percent expect less than last year and 25 percent expect no bonus.

Half of this group is very satisfied with their compensation, 25 percent are somewhat satisfied, 20 percent are satisfied and 5 percent are somewhat dissatisfied and none that were dissatisfied. This compares to the overall results of 29 percent, 31 percent, 14 percent, 21 percent and 5 percent, respectively.

The majority (70 percent) of this group does not anticipate changing positions, while 10 percent do and 20 percent are undecided, compared with 63 percent, 17 percent and 20 percent, respectively, of the overall respondents.

Sixty-five percent of this group has been employed by their present employer for six years or less and 80 percent have been employed in their current position for one to six years.

Of the overall respondents who said they received a bonus or other incentive pay of $10,000 or more, there are some interesting differences from the overall results. For example, 21 percent are 40 years old or younger, 47 percent are 41 to 50 and 32 percent are over 50, compared with 23 percent, 40 percent and 37 percent, respectively.

Of the group that received a bonus of $10,000 or more, none makes less than $100,000; 23 percent makes $100,000-$200,000; 46 percent make $200,000-$300,000; 26 percent make $300,000-$350,000 and 4 percent make more than $350,000. That compares to 14 percent, 26 percent earn $100,000 to $200,000, 43 percent earn $200,000 and $300,000, 12 percent and 5 percent, respectively, of the overall results.

Much less of this bonus subgroup group expect no raise compared to overall respondents: 18 percent vs. 34 percent expect no raise, 61 percent expect a salary increase of 4 percent or less; 19 percent expect a raise of 4-10 percent and 2 percent expect a 10-12 percent increase.

Only 2 percent of this group expects no bonus this year, compared to 47 percent of the overall respondents.

The bonus group is a little more satisfied with their compensation: 62 percent said they are very or somewhat satisfied compared to 60 percent of overall respondents and 18 percent are somewhat or very dissatisfied compared to 26 percent of overall respondents.

Fewer of this group plan to move on. Fifty-eight percent do not anticipate changing positions, 16 percent do and 26 percent are undecided, compared with 63 percent, 17 percent and 20 percent, respectively.

That’s all for this year’s CMIO Compensation Survey results. We look forward to crunching the numbers next year to see what has changed.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.